Heron Therapeutics, Inc. /de/
Ticker: HRTX
| Insider | Title |
|---|---|
| Adam Morgan | Director |
| Balaji Venkataraman | See Footnote 2 |
| Barry D Quart | Chief Executive Officer, Director |
| Capital Holdings Llc Velan | See Footnote 2 |
| Capital Investment Management Lp Velan | See Footnote 2 |
| Capital Management Llc Velan | See Footnote 2 |
| Capital Management Lp Rubric | See Footnote 1 |
| Capital Master Fund Lp Velan | See Footnote 2 |
| Craig A Collard | Chief Executive Officer, Director |
| Craig A Johnson | Director |
| David Efraim Rosen | See Footnote 1 |
| David Leslie Szekeres | EVP, Chief Operating Officer |
| Ira Duarte | EVP, Chief Financial Officer |
| John Poyhonen | President CCO |
| Kevin Kotler | Director |
| Kimberly Manhard | EVP, Drug Development |
| Lisa Peraza | VP, Chief Accounting Officer |
| Michael Kaseta | Director |
| Sharmila Dissanaike | Director |
| Stephen Davis | CEO, Director |
| Susan Rodriguez | Director |
| Waage Christian | Director |
| William P Forbes | EVP, Chief Development Officer |